UnitedHealth Keeps Raising Guidance. Here's What a $10,000 Investment Could Be Worth if the Turnaround Sticks.

Source Motley_fool

Key Points

  • UnitedHealth recently raised its 2026 adjusted earnings guidance for the third time this year, to at least $20.50 per share.

  • Raising premiums, cutting certain benefits, and exiting less profitable markets lifted UnitedHealth’s health insurance operating margin to 3.3%.

  • Optum has restructured operations and exited less attractive contracts, while automation and AI could streamline administration in its technology business.

  • Motley Fool Issues Rare "Total Conviction" Buy Alert ›

UnitedHealth Group (NYSE: UNH) may finally be turning a corner after a difficult stretch. These days, with management repeatedly raising earnings guidance (most recently on Oct. 13) and profitability showing signs of recovery, could the healthcare giant be poised for a comeback?

Here's what a $10,000 investment could become if the turnaround holds.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »

A stethoscope and red plastic toy heart on top of a financial chart.

Image source: Getty Images.

UnitedHealth is finally putting its turnaround into action

For much of the past two years, UnitedHealth has struggled to convince investors it could turn its business around. But that picture is starting to change. In fact, UnitedHealth has now raised its full-year earnings guidance three times in 2026.

Its latest third-quarter results offered another encouraging sign that management's efforts are starting to pay off. Specifically, the company reported adjusted earnings of $4.69 per share, compared with $2.92 in the same quarter last year. But more importantly, management raised its full-year 2026 adjusted earnings outlook to at least $20.50 per share, up from its previous range of between $19.50 and $20.00.

Still, for investors, the bigger question now is whether these improvements represent a temporary rebound or the beginning of a more sustainable recovery. So far, the latest results have given more reasons to be optimistic.

Medicare Advantage is becoming a strong earnings driver

One of UnitedHealth's biggest challenges has been rising medical costs across its insurance business, particularly in Medicare Advantage. In response, the company had to begin making big changes to the business. These included raising premiums, reducing certain benefits, and exiting less profitable markets.

The strategy meant sacrificing short-term membership growth, but the results suggest that this new approach is working. In fact, in the third quarter, the health insurance segment generated $2.8 billion in operating earnings, compared with $1.8 billion a year earlier. Plus, its operating margin improved to 3.3% from 2.1%.

Looking ahead, management sees opportunities to further improve its Medicare Advantage business in 2027. Specifically, the company is focusing on markets and products where it believes it can achieve more durable margins, including special needs plans for seniors with more complex healthcare needs.

Meanwhile, UnitedHealth's healthcare services business is turning into a strong growth driver.

Optum could become another major growth catalyst

Perhaps one of UnitedHealth's most important competitive advantages comes from Optum, which operates across healthcare delivery, pharmacy services, and technology segments. This diversification is valuable as the healthcare industry looks for ways to trim costs, improve efficiency, and coordinate healthcare.

There is an additional long-term opportunity in Optum's technology operations. For example, automation and artificial intelligence (AI) could help streamline administrative processes and improve the way patients and providers interact with the healthcare system.

All told, if existing operations continue to recover and productivity improvements from automation and AI materialize, UnitedHealth would be better positioned to deliver stronger earnings growth. That raises the question of what stronger earnings growth could mean for investors.

The turnaround could reward patient investors

Ultimately, if the company executes its turnaround plans well, investors could be rewarded. To illustrate, starting with its 2026 adjusted earnings per share (EPS) projection of at least $20.50 and applying the low end of management's long-term earnings growth target of 13%-16%, adjusted EPS could reach around $23.17 in 2027.

From there, applying a 22 price-to-earnings (P/E) ratio produces a price target of around $510 per share, which would turn a $10,000 investment into about $12,400.

In the table below, I used a base case assuming 14.5% growth and a slightly higher 23 P/E, and a bull case using the upper end of growth and a 24 multiple.

Scenario 2027 EPS growth 2027 adjusted EPS P/E multiple Target price Upside vs. $412.02 last close $10,000 could become
Conservative 13% $23.17 22 $510 24% $12,400
Base 14.5% $23.47 23 $540 31% $13,100
Bull 16% $23.78 24 $571 39% $13,900

Data source: Calculations by the author.

Overall, if management can sustain the turnaround and restore profitability across the company, investors could be looking at a much stronger investment case in the years ahead.

Should you buy stock in UnitedHealth Group right now?

Before you buy stock in UnitedHealth Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $327,620!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $959,410!*

Now, it’s worth noting Stock Advisor’s total average return is 802% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 17, 2026.

Rick Orford has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Market News Today Australia: VIX Jumps Nearly 19%, Gold Hits One-Year Low and Nasdaq 100 FallsNasdaq 100 falls 2.67%, gold hits a one-year low and WTI settles at US$85.72. See what Australian traders are watching ahead of Nvidia earnings.
Author  Mitrade Team
Yesterday 02: 29
Nasdaq 100 falls 2.67%, gold hits a one-year low and WTI settles at US$85.72. See what Australian traders are watching ahead of Nvidia earnings.
placeholder
Stocks, Gold, and Asia Bleed $2.2 Trillion: Top 5 Factors That Triggered the CrashGlobal markets lost roughly $2.2 trillion on November 16 as US stocks, precious metals, and Asian equities sold off together. Technology and AI-linked names led the decline.However, the rout did not s
Author  Beincrypto
Yesterday 02: 49
Global markets lost roughly $2.2 trillion on November 16 as US stocks, precious metals, and Asian equities sold off together. Technology and AI-linked names led the decline.However, the rout did not s
placeholder
Nvidia faces its biggest earnings test yet — why Silicon Valley billionaires want Jensen Huang backNvidia faces a critical earnings test as investors weigh its AI growth outlook and leadership uncertainty. Discover why Silicon Valley billionaires want Jensen Huang back, what it could mean for Nvidia shares and how the results may shape the broader AI trade.
Author  Mark Garro
Yesterday 03: 24
Nvidia faces a critical earnings test as investors weigh its AI growth outlook and leadership uncertainty. Discover why Silicon Valley billionaires want Jensen Huang back, what it could mean for Nvidia shares and how the results may shape the broader AI trade.
placeholder
Gold Price Today: Can XAU/USD Hold $3,870? | Mitrade AUGold rebounds near US$3,870 after hitting a one-year low. Explore XAU/USD support, Fed risks and what the outlook means for Australian traders.
Author  Mitrade Team
18 hours ago
Gold rebounds near US$3,870 after hitting a one-year low. Explore XAU/USD support, Fed risks and what the outlook means for Australian traders.
placeholder
Market News Today Australia: Gold Below US$3,900, US Stocks Fall as Nvidia Delivers Strong EarningsUS retail sales rise 0.2%, gold stays below US$3,900 and Nvidia beats earnings estimates. Explore the outlook for Australian CFD traders.
Author  Mitrade Team
1 hour ago
US retail sales rise 0.2%, gold stays below US$3,900 and Nvidia beats earnings estimates. Explore the outlook for Australian CFD traders.
goTop
quote